Bin Zhang

Bin Zhang has a diverse work experience in the pharmaceutical and healthcare industry. Bin is currently working as SVP, Clinical Development at BioAtla, Inc. Prior to that, they held the position of SVP, Head of Clinical Development at Pyxis Oncology. Bin has also worked at Ipsen as Vice President, Global Asset Lead, Oncology and Vice President, Global Clinical Development. Bin has experience in various roles at KBP BioSciences, Bristol-Myers Squibb, Abt Bio-Pharma Solutions, Inc. (subsidiary of Abt Associates Inc.), Boston Health Economics, New England Healthcare Institute, and Peking Union Medical College Hospital (PUMCH).

Bin Zhang has an MSc. degree in Health Policy and Management from Harvard T.H. Chan School of Public Health. They also have an MD degree in Medicine from China Medical University.